Skip to main content
Skip to main navigation
Search
The University of British Columbia
UBC - A Place of Mind
The University of British Columbia
campus
UBC Search
UBC Search
UBC COVID-19 Research
Main menu
Home
Research Projects
All Research Projects
Medical Response
Social and Policy Response
COVID-19 Researchers
COVID-19 Researchers
Funding & Resources
Funding Opportunities
Initiatives & Websites
Ethics and Approvals for COVID-19 Research
Access to High-Performance Computing and Storage
Facilities
Publications
News
News
UBC Researchers in the News
For Media
For Media
Donate
You are here
Home
|
People
|
Pieter Cullis
Pieter Cullis
Professor
Department of Biochemistry and Molecular Biology, Department of Botany
Faculty of Medicine
COVID-19 Research Area(s)
Vaccines & Treatments
Collaborators Sought
Academic, Community, Government, Healthcare, Industry, Non-profit
COVID-19 Projects (UBC Lead)
COVID-19 Therapeutics
Using nanoparticles to deliver antibody therapy against COVID-19
COVID-19 Projects (UBC Collaborator)
Anticoagulant RNA-based therapies for SARS-CoV-2 related thrombosis
Related News, Media and Articles
B.C. scientist instrumental in development of COVID-19 vaccine honoured by alma mater
How universities are helping us manage and rebuild from the COVID-19 pandemic
This Canadian scientist helped lay the groundwork for pandemic-taming COVID-19 vaccines
Meet the Canadian scientist who paved the way for groundbreaking mRNA COVID vaccines
How mRNA is transforming the way we treat illnesses from flu to cancer
UBC professor Pieter Cullis awarded for role in COVID-19 vaccines
Halting Progress and Happy Accidents: How mRNA Vaccines Were Made
Dr. Pieter Cullis and colleagues win VinFuture Foundation’s first global sci-tech award
Dr. Pieter Cullis awarded Prince Mahidol Award for ground-breaking work on lipid nanoparticles
The tangled history of mRNA vaccines
Don’t shoot the messenger—the pioneers of mRNA
The history behind the B.C. biotech that helped make the Pfizer vaccine work
UBC researchers help develop Pfizer COVID-19 vaccine
Why grandparents can’t find vaccines: Scarcity of niche biotech ingredients
BioNTech, Moderna shore up supplies of key COVID-19 vaccine ingredients
The first Covid-19 vaccines have changed biotech forever
Vancouver-based company plays role in Pfizer COVID-19 vaccine
B.C. announces vaccination game plan
B.C. biotech plays key role in vaccine breakthrough